Find out more about our work to increase access to innovative healthcare products. Read our latest press releases and dive deeper with insight articles and primers on innovative finance for healthcare.
Evans Mburu, our implementation executive, knows first-hand TB’s devastating impact. Watch Evans share his story about taking TB treatment.
The longer a mosquito population is exposed to a single class of insecticides, the longer it has had to build resistance. Dr. Tom McLean from IVCC explores three insecticide tools at market and in development to battle resistance.
Vicky will lead on all aspects of financial management, control and reporting and she joins MedAccess' Senior Management Team.
MedAccess' volume guarantee will help increase availability of an innovative treatment for latent tuberculosis.
Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine ahead of key policy and funding decisions.
New malaria technologies are tackling the problem of insecticide resistance in mosquitos. Dr. Tom McLean from IVCC discusses how to get these new tools to the people who need them.
MedAccess CEO Michael Anderson joined Laura Frigenti and Simba Makoni to discuss trends in financing for global health and how the COVID-19 pandemic has affected funding.
Extension will support UNICEF's work to accelerate access to essential supplies for countries around the world
Ghana will begin its COVID-19 immunisation campaign using syringes provided through MedAccess' support for UNICEF.
Through the Global Access Initiative, we are helping to increase access viral load testing through the Panther platform. Ahead of World AIDS Day 2020, two laboratory technicians in Kenya and Zambia told us how Panther is helping them to better serve patients.
Michael joined an ODI panel to assess the immediate development finance institutions' (DFI) response to the COVID-19 pandemic and how DFI’s could support public sector investment in the health sector.
Considerable progress has been made to improve girls’ health and to empower and educate them to make safer decisions about their bodies. Here are three major concerns for the health of girls around the world.
Our 2019 Annual Report highlights how our guarantees secured lower prices and supported sustainable access to healthcare products for people living in underserved communities.
New support for UNICEF to secure vital COVID-19 medical products, including diagnostic tests and clinical management supplies, for low- and middle-income countries.
Academic and scientific communities, and pharmaceutical companies, have moved away from business as usual in the pursuit of medical products to tackle coronavirus.
Whilst the progress against infectious diseases has been nothing short of remarkable, the burden of non-communicable diseases (NCDs) has increased.
MedAccess is pleased to announce the appointment of Hema Srinivasan as the social finance company’s new Chief Access Officer. Hema will take up her new role in March 2020.
The price of new BASF Interceptor® G2 mosquito nets will be reduced by 40% for underserved communities thanks to a new MedAccess partnership
MedAccess has been invited to showcase how a social finance company can accelerate the delivery of new and better products in the fight against diseases.
An independent ranking of 20 of the world’s leading pharmaceutical companies on their efforts to improve access to medicine in low- and middle-income countries.
The importance of making routine HIV tests more accessible as part of the effort to reach the U.N.’s ambitious goal to eliminate HIV transmission by the year 2030.
The Hologic Global Access Initiative was launched at the International AIDS Society Conference in July 2018, setting a new standard for affordable and transparent pricing.
Despite the efficacy and availability of quality-assured implants, evidence from national family planning programs has suggested a significant unmet need.